en · de · es · fr · pt
cardarine-notes.peptides6579.com › Faq › Regulatory Status And Detection Context — Quick Reference

Regulatory Status And Detection Context — Quick Reference

By Editorial Desk · published 2025-07-08 · last reviewed 2025-07-29 · Faq

GW501516 is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.

Last reviewed on 2025-07-29. Where a claim depends on a specific study, the study is described rather than over-claimed.

Regulatory Status and Detection Context

A persistent misconception is that cardarine is a fat-burning drug or a safe alternative to anabolic steroids. No approved therapeutic product exists, and human safety data are limited. The tumor findings in rodents remain a central concern in scientific reviews. Products sold online may contain inaccurate labels, impurities, or different compounds entirely, which complicates any assessment of effects. Independent testing of such products has reported frequent mislabeling. For these reasons, discussions in the literature emphasize risks and unknowns rather than benefits.

Cardarine is not approved for human therapeutic use in any major jurisdiction. It appears on the World Anti-Doping Agency Prohibited List as a PPARδ agonist within the hormone and metabolic modulators category. Sports organizations test for it because it has been detected in athlete samples and seized products. Regulatory actions against marketed research chemical versions have occurred in several countries, though enforcement varies. Availability through unregulated channels complicates oversight.

Analytical laboratories typically identify cardarine and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is a common matrix in anti-doping testing, while blood and tissue may be used in research settings. Detection windows depend on the assay, the sample matrix, and the compound's metabolism. Because cardarine is extensively metabolized, laboratories often target specific metabolites to improve sensitivity and confirmation. Reference standards are required for reliable quantification. Method validation includes checks for selectivity, linearity, and carryover.

Background and Regulatory History

Regulatory bodies treat GW501516 as a prohibited substance in competitive sport. The World Anti-Doping Agency added it to the prohibited list, and it falls under classes covering metabolic modulators and hormone-related agents. It is not approved by drug regulators for human use, and it is not a lawful dietary supplement. Products sold under the cardarine name may contain unlisted ingredients or different compounds. Because no approved product exists, quality and identity are not guaranteed by pharmaceutical manufacturing standards.

Cardarine is a common name for the investigational chemical GW501516, also written GW-1516. It was developed as a peroxisome proliferator-activated receptor delta agonist for metabolic conditions such as dyslipidemia. Early research focused on lipid handling and energy use in skeletal muscle and other tissues. The compound was never approved as a medicine. In public discussion, it is often grouped with performance-enhancing substances, although its receptor target differs from that of anabolic steroids or selective androgen receptor modulators. Regulatory and health authorities have issued warnings about its use.

GW501516 acts on PPARδ, a nuclear receptor that helps regulate fatty acid oxidation and energy homeostasis. In animal studies, activation of this receptor was associated with increased endurance and changes in lipid metabolism. Human trials examined effects on blood lipids and other metabolic markers, but the compound did not advance to approval. Rodent studies later reported tumors in multiple tissues at doses used in those experiments. Whether those findings translate to human risk remains uncertain, and the clinical relevance of the animal data is still debated.

Cardarine at a glance

PropertyValueNotes
Regulatory statusNot approved for human therapeutic useNo marketing authorization identified in major jurisdictions.
Anti-doping classPPARδ agonist; hormone and metabolic modulatorsListed on the WADA Prohibited List.
Common test matrixUrineAlso blood and tissue in research settings.
Typical analytical methodLC-MS/MSTargets parent compound and metabolites.
Major safety signalTumor findings in rodentsHuman relevance not established; limited human data.

Identity and Pharmacological Mechanism

The compound is typically described as a laboratory compound rather than a therapeutic product. Published reports have explored its role in lipid disorders, insulin sensitivity, and exercise metabolism, yet no major drug regulator has approved it for medical use. Commercial samples sold under the cardarine name may vary in purity and identity. Analytical confirmation is therefore necessary when the material is discussed in scientific or regulatory contexts. Its classification as a prohibited substance in sport further shapes how it is studied and reported.

Cardarine is a common name for GW501516, a synthetic compound studied for its effects on lipid and glucose metabolism. It functions as an agonist at peroxisome proliferator-activated receptor delta, or PPARδ, a nuclear receptor that influences gene expression. The molecule is not a steroid, nor is it a selective androgen receptor modulator. It is also known in research and sports literature as GW-501516 and endurobol. Early laboratory work examined its metabolic activity in cell cultures and animal models.

Activation of PPARδ changes transcription of genes involved in fatty acid transport, mitochondrial function, and skeletal muscle fuel preference. In rodent studies, pharmacological PPARδ activation was associated with increased endurance and altered body composition. These findings generated interest in performance enhancement, but species differences and study designs limit direct extrapolation to humans. Small human trials were conducted in the 2000s and later discontinued. The extent to which cardarine produces similar metabolic or performance effects in people remains an open question.

Related pages on this site

Background and Regulatory Status

Legal status varies by country. In some places, cardarine is controlled under medicines or psychoactive substances laws; in others, it may be sold with minimal oversight as a research chemical. Customs agencies have intercepted shipments, and several national health agencies have issued warnings about products marketed for bodybuilding or performance enhancement. The lack of a standardized pharmaceutical supply means identity, purity, and contamination levels can differ widely between samples. These factors make cardarine a regulatory and public health concern rather than a conventional prescription drug.

Cardarine is a common name for GW501516, a synthetic compound first described in the 1990s as a selective agonist of the peroxisome proliferator-activated receptor delta. It was studied in preclinical models for metabolic and cardiovascular conditions, but it has not been approved as a medicine in the United States, Europe, or other major jurisdictions. Retail products labeled as cardarine are generally research chemicals or supplements, not pharmaceutical formulations. Because human safety and efficacy data remain limited, regulatory agencies treat it as an unapproved substance rather than a therapeutic product.

Sporting authorities added GW501516 to prohibited lists after it appeared in athlete samples and online markets. The World Anti-Doping Agency classifies it as a hormone and metabolic modulator, and its use can lead to an anti-doping rule violation. Some early laboratory work suggested effects on fatty acid oxidation and endurance-related metabolism in animals, but those findings do not establish safe or effective use in people. Reports of adverse events in humans are scarce and often anecdotal, which complicates risk assessment.

Supporting material

=== Forestry === In commercial forestry, the transplanting of crop trees to new locations often requires an accompanying ectomycorrhizal partner. This is especially true of trees that have a high degree of specificity for their mycobiont, or trees that are being planted far from their native habitat among novel fungal species. This has been repeatedly shown in plantations involving obligate ectomycorrhizal trees, such as Eucalyptus and Pinus species. Mass planting of these species often requires an inoculum of native EcM fungi for the trees to prosper. Sometimes ectomycorrhizal plantation species, such as pine and eucalyptus, are planted and promoted for their ability to act as a sink for atmospheric carbon. However, the ectomycorrhizal fungi of these species also tend to deplete soil carbon, making this use of plantations controversial.

=== Controversy over ballot traceability === The Election Commission also faced allegations that the barcodes and QR codes on the election ballots compromised voter secrecy and might be unconstitutional. The controversy began after social media users analyzed the codes from photos of ballot papers, discovering that they were unique per ballot and could be matched to the counterfoil containing individual voters' signatures, theoretically allowing any individual's vote to be determined. On 14 February, the Election Commission acknowledged that the ballot codes could indeed be used to link voters to their ballots, but defended the process as a legal measure intended to prevent voter fraud, stating that the ballots, counterfoils, and voter registration data were stored separately. In response, critics argued that the possibility of voter traceability is already inherently unconstitutional, with many citing as precedent the Constitutional Court decision nullifying the 2006 election due to voting booths being positioned with voters' backs towards the public. Legal scholar Prinya Thaewanarumitkul also pointed out that the Election Commission's regulations actually require counterfoils to be kept with the ballots and argued that regardless of storage, the ballots could be photographed during the counting process. On 13 February, 12 petitions were submitted to the Office of the Ombudsman, which on 16 February sent a letter to the Election Commission asking it to address the complaints within seven days, which was later extended by seven more days on the Commission's request.

=== CANDU reactors === Natural uranium, with 0.72% 235U, is usable as nuclear fuel in reactors designed specifically for this, such as the heavy-water CANDU reactor. By making use of non-enriched uranium, such reactor designs give a nation access to nuclear power for the purpose of electricity production without necessitating the development of fuel enrichment capabilities, which are often seen as a prelude to weapons production.

Dapagliflozin can cause low blood sugar when combined with insulin. To lessen the risk of developing ketoacidosis after surgery, the US FDA approved changes to the prescribing information for SGLT-2 inhibitors to recommend they be stopped temporarily before scheduled surgery. Canagliflozin, dapagliflozin, and empagliflozin should each be stopped at least three days before, and ertugliflozin should be stopped at least four days before scheduled surgery. The glucose-lowering effect of dapagliflozin starts to diminish in people with chronic kidney disease with reduced kidney function (eGFR <45mL/min) and may not be as effective for glycemic control. However, studies have demonstrated a renoprotective effect in reducing kidney function decline, dapagliflozin can still be used to reduce kidney function decline regardless of diabetes status. Therefore, while dapagliflozin can be used in people with diabetes and chronic kidney disease to prevent kidney function decline, further interventions may be needed for glycemic control.

=== Analogues and derivatives === Analogues and derivatives of nicotine are known. These compounds, often structurally similar and sharing affinity for nicotinic acetylcholine receptors, have applications in pharmacology (e.g., smoking cessation), pest control, and neuroscience research (e.g., multiple domain cognitive enhancement, neuroprotection).

Sources: en.wikipedia.org

Notes from published material

=== Postnatal development === The postnatal population of dermal macrophages is achieved by the infiltration of circulating monocytes given proper CCR2 signalling, a pathway responding to chemokines. The infiltration of circulating monocytes can also be triggered through the upregulation of pro-inflammatory cytokines and chemicals such as sodium chloride. The infiltration of bone-marrow-derived monocytes generated postnatally creates a distinct population of dermal macrophages. They are LY6Chi monocytes, a type of circulating monocyte in the blood. The entry of LY6Chi monocytes to the dermis is CCR2-pathway-dependent. Their subsequent differentiation will create the postnatal population. The generation of dermal macrophages is highlighted by the expression of cell markers such as CD64, MERTK and the downregulation of CCR2.

=== Refrigeration === Around 1938, following a request by Numero, Jones began designing the Thermo Control Model A automatic truck refrigeration unit. Jones designed the portable air-cooling unit for trucks carrying perishable food to prevent spoilage. The Model A refrigeration equipment was attached to undercarriages of trucks. Chilled air was transported to the inside of the trailer via refrigerant tubing. Because Model A was too heavy, Jones later developed the Model B, which was smaller and lighter, but not durable. In 1941, Jones completed development of the Model C, which was mounted to the front of the truck, was compact, light, and withstood road travel vibrations. In 1939, Jones filed for a patent for the Model A and received a patent for it on July 12, 1949. Numero sold his movie sound equipment business to RCA and formed a new company in partnership with Jones, the U.S. Thermo Control Company (later the Thermo King Corporation) which became a $3 million business by 1949. Portable cooling units designed by Jones were especially important during World War II, preserving blood, medicine, and food for use at army hospitals and on open battlefields. Model C units were initially manufactured for military use, but following the war the units became available for commercial use as well.

In 2008, Freeman was cast in the action-thriller Wanted, a loose adaptation of the comic book miniseries by Mark Millar and J. G. Jones. The plot revolves around Wesley Gibson (James McAvoy), a frustrated account manager who discovers that he is the son of a professional assassin and decides to join the Fraternity, a secret society of which Sloan (Freeman) is the leader. Principal photography took place in Chicago; co-star rapper Common remarked on the set atmosphere: "Freeman is a cool guy. He'd be walking around joking and singing and just dancing. You know, artists are free and I just felt the freedom in him." The film received generally favorable reviews; Peter Howell of Toronto Star thought it was original and one of Freeman's bolder performances to date. Freeman narrated The Love Guru (2008), before appearing in The Dark Knight (2008), the second installment of Christopher Nolan's Dark Knight Trilogy, in which he reprised his role as Lucius Fox. Freeman returned to Broadway in 2008 after an eighteen-year absence to co-star with Frances McDormand and Peter Gallagher in Clifford Odets' play, The Country Girl, directed by Mike Nichols. Freeman continued to accept roles in a diverse range of genres. In 2009, Freeman starred opposite Antonio Banderas in the heist movie Thick as Thieves. Next, he collaborated with Christopher Walken and William H. Macy for the comedy The Maiden Heist. For some time, Freeman expressed a desire to do a film based on Nelson Mandela.

Chitosan is a linear polysaccharide composed of randomly distributed β-(1→4)-linked D-glucosamine (deacetylated unit) and N-acetyl-D-glucosamine (acetylated unit). It is made by treating the chitin shells of shrimp and other crustaceans with an alkaline substance, such as sodium hydroxide. Chitosan has a number of commercial and possible biomedical uses. It can be used in agriculture as a seed treatment and biopesticide, helping plants to fight off fungal infections. In winemaking, it can be used as a fining agent, also helping to prevent spoilage. In industry, it can be used in a self-healing polyurethane paint coating. In medicine, it is useful in bandages (in the form of chitosan hydrocolloid dressing) to reduce bleeding and as an antibacterial agent; it can also be used to help deliver drugs through the skin.

=== Inhibition === NADPH oxidase can be inhibited by apocynin, nitric oxide (NO), and diphenylene iodonium. Apocynin acts by preventing the assembly of the NADPH oxidase subunits. Apocynin decreases influenza-induced lung inflammation in mice in vivo and so may have clinical benefits in the treatment of influenza. Inhibition of NADPH oxidase by NO blocks the source of oxidative stress in the vasculature. NO donor drugs (nitrovasodilators) have therefore been used for more than a century to treat coronary artery disease, hypertension, and heart failure by preventing excess superoxide from deteriorating healthy vascular cells. More advanced NADPH oxidase inhibitors include GKT-831 (Formerly GKT137831), a dual Inhibitor of isoforms NOX4 and NOX1 which was patented in 2007. The compound was initially developed for Idiopathic pulmonary fibrosis and obtained orphan drug designation by the FDA and EMA at end of 2010.

Sources: en.wikipedia.org

Frequently asked questions

Is cardarine approved for any medical use?

No. Cardarine has not received approval for human therapeutic use in major jurisdictions. It remains an investigational compound.

Why is cardarine prohibited in sport?

It is classified as a PPARδ agonist on the WADA Prohibited List. Anti-doping laboratories can detect it and its metabolites in urine. Its use is banned in competition and usually out of competition.

What is known about cardarine and cancer?

Rodent studies reported increased tumor incidence at multiple sites. The human relevance remains uncertain, but the findings contributed to discontinuation of development. No long-term human cancer data are available.

Is cardarine a selective androgen receptor modulator?

No. Cardarine is a PPARδ agonist, while selective androgen receptor modulators act on androgen receptors. The two classes differ in receptor target and downstream effects.

Network